FI932680A - Fusionspolypeptider - Google Patents

Fusionspolypeptider Download PDF

Info

Publication number: FI932680A
Authority: FI; Finland
Prior art keywords: fusionspolypeptider
Prior art date: 1990-12-13

Application number

FI932680A

Other languages

Finnish (fi)

Other versions

FI932680A0 (en

Inventor

Teresa M Kubiak

Satish K Sharma

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-13

Filing date

1993-06-11

Publication date

1993-06-11

1993-06-11 Application filed by Upjohn Co filed Critical Upjohn Co

1993-06-11 Publication of FI932680A publication Critical patent/FI932680A/en

1993-06-11 Publication of FI932680A0 publication Critical patent/FI932680A0/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Vascular Medicine (AREA)
Peptides Or Proteins (AREA)

FI932680A 1990-12-13 1993-06-11 Fusionspolypeptider FI932680A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US62672790A	1990-12-13	1990-12-13

Publications (2)

Publication Number	Publication Date
FI932680A true FI932680A (en)	1993-06-11
FI932680A0 FI932680A0 (en)	1993-06-11

Family

ID=24511577

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI932680A FI932680A0 (en)	1990-12-13	1993-06-11	Fusionspolypeptider

Country Status (13)

Country	Link
EP (1)	EP0561971A1 (en)
JP (1)	JPH06503473A (en)
AU (1)	AU662508B2 (en)
CA (1)	CA2094512A1 (en)
CZ (1)	CZ109393A3 (en)
FI (1)	FI932680A0 (en)
HU (1)	HUT69963A (en)
IE (1)	IE914347A1 (en)
NO (1)	NO932148L (en)
RU (1)	RU2114119C1 (en)
SK (1)	SK60893A3 (en)
TW (1)	TW213923B (en)
WO (1)	WO1992010576A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050272652A1 (en)	1999-03-29	2005-12-08	Gault Victor A	Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
US6759393B1 (en)	1999-04-12	2004-07-06	Pfizer Inc.	Growth hormone and growth hormone releasing hormone compositions
JP2000350590A (en) *	1999-04-12	2000-12-19	Pfizer Prod Inc	Growth hormone and growth hormone releasing hormone composition
WO2001036643A1 (en) *	1999-11-19	2001-05-25	Transkaryotic Therapies, Inc.	Nucleic acid construct for optimized production of products
EP1205551A1 (en) *	2000-11-09	2002-05-15	Pfizer Products Inc.	Growth hormone and growth hormone releasing hormone compositions
JP4865565B2 (en)	2003-12-09	2012-02-01	ノヴォノルディスクアー／エス	Controlling food selection using GLP-1 agonists
EP1758575A1 (en)	2004-06-11	2007-03-07	Novo Nordisk A/S	Counteracting drug-induced obesity using glp-1 agonists
JP2008530130A (en)	2005-02-11	2008-08-07	アミリン・ファーマシューティカルズ，インコーポレイテッド	GIP analogs and hybrid polypeptides with selectable properties
US8263545B2 (en)	2005-02-11	2012-09-11	Amylin Pharmaceuticals, Inc.	GIP analog and hybrid polypeptides with selectable properties
WO2007103515A2 (en) †	2006-03-06	2007-09-13	Amunix, Inc.	Unstructured recombinant polymers and uses thereof
US7855279B2 (en)	2005-09-27	2010-12-21	Amunix Operating, Inc.	Unstructured recombinant polymers and uses thereof
US8497240B2 (en)	2006-08-17	2013-07-30	Amylin Pharmaceuticals, Llc	DPP-IV resistant GIP hybrid polypeptides with selectable properties
BR122021021381B1 (en)	2009-02-03	2023-05-16	Amunix Pharmaceuticals, Inc	METHOD FOR IMPROVING A PROPERTY OF A BIOLOGICALLY ACTIVE PROTEIN
US8716448B2 (en)	2009-02-03	2014-05-06	Amunix Operating Inc.	Coagulation factor VII compositions and methods of making and using same
EP2528935B1 (en)	2010-01-29	2019-03-27	Archer-Daniels-Midland Company	Peptide domains that bind small molecules of industrial significance
AU2013204636B2 (en)	2012-02-15	2016-04-14	Bioverativ Therapeutics Inc.	Recombinant Factor VIII proteins
HUE060629T2 (en)	2012-02-15	2023-03-28	Bioverativ Therapeutics Inc	Factor viii compositions and methods of making and using same
US10548953B2 (en)	2013-08-14	2020-02-04	Bioverativ Therapeutics Inc.	Factor VIII-XTEN fusions and uses thereof
UA126016C2 (en)	2015-08-03	2022-08-03	Біовератів Терапеутікс Інк.	Factor ix fusion proteins and methods of making and using same
CN111051338A (en) *	2017-06-29	2020-04-21	乌雷卡有限公司	Prodrug peptides with improved pharmacological properties

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4703004A (en) *	1984-01-24	1987-10-27	Immunex Corporation	Synthesis of protein with an identification peptide
US4569794A (en) *	1984-12-05	1986-02-11	Eli Lilly And Company	Process for purifying proteins and compounds useful in such process
CA1340522C (en) *	1987-03-10	1999-05-04	Heinz Dobeli	Fusion proteins containing neighbouring histidines for improved purification
AU625787B2 (en) *	1989-06-16	1992-07-16	Pharmacia & Upjohn Company	Stabilized, potent grf analogs
ATE139572T1 (en) *	1990-04-09	1996-07-15	Upjohn Co	METHOD FOR PURIFYING RECOMBINANT PROTEINS AND USEFUL PRODUCTS THEREFOR

1991
- 1991-12-12 CZ CS931093A patent/CZ109393A3/en unknown
- 1991-12-12 HU HU9301705A patent/HUT69963A/en unknown
- 1991-12-12 RU RU93045577A patent/RU2114119C1/en active
- 1991-12-12 SK SK60893A patent/SK60893A3/en unknown
- 1991-12-12 EP EP92901817A patent/EP0561971A1/en not_active Withdrawn
- 1991-12-12 WO PCT/US1991/009152 patent/WO1992010576A1/en not_active Application Discontinuation
- 1991-12-12 AU AU91165/91A patent/AU662508B2/en not_active Ceased
- 1991-12-12 CA CA002094512A patent/CA2094512A1/en not_active Abandoned
- 1991-12-12 JP JP4501996A patent/JPH06503473A/en active Pending
- 1991-12-13 IE IE434791A patent/IE914347A1/en not_active Application Discontinuation
- 1991-12-17 TW TW080109839A patent/TW213923B/zh active
1993
- 1993-06-11 FI FI932680A patent/FI932680A0/en not_active Application Discontinuation
- 1993-06-11 NO NO93932148A patent/NO932148L/en unknown

Also Published As

Publication number	Publication date
CA2094512A1 (en)	1992-06-14
NO932148D0 (en)	1993-06-11
TW213923B (en)	1993-10-01
EP0561971A1 (en)	1993-09-29
NO932148L (en)	1993-08-09
AU9116591A (en)	1992-07-08
JPH06503473A (en)	1994-04-21
HUT69963A (en)	1995-09-28
HU9301705D0 (en)	1993-10-28
CZ109393A3 (en)	1994-01-19
AU662508B2 (en)	1995-09-07
IE914347A1 (en)	1992-06-17
SK60893A3 (en)	1993-10-06
RU2114119C1 (en)	1998-06-27
FI932680A0 (en)	1993-06-11
WO1992010576A1 (en)	1992-06-25

Legal Events

Date	Code	Title	Description
1996-07-16	HC	Name/ company changed in application	Owner name: PHARMACIA & UPJOHN COMPANY
1998-06-30	FD	Application lapsed

Publication	Publication Date	Title
ATA150090A (en)	1992-08-15	HOERGERAET
FI934577A0 (en)	1993-10-15	SKYDDSHYLSA FOER ENVAEGSVENTIL
FI932680A (en)	1993-06-11	Fusionspolypeptider
ATA210290A (en)	1991-10-15	LOTPILLE
ATA80690A (en)	1997-12-15	ALPINSCHI
FI931781A0 (en)	1993-04-20	PLOEJNINGSVERKTYG
FI923773A (en)	1992-08-21	VAOTSUGARE
ATA200090A (en)	1991-06-15	PIANINO
FI932807A0 (en)	1993-06-17	Braensleelement Foer kaerneactor
SE9102229L (en)	1992-01-25	SPAENNANORDNING
ATA209290A (en)	1992-10-15	DIARAEHMCHEN
ATA237490A (en)	1991-12-15	RINNENSTEIN
DK124790D0 (en)	1990-05-18	VIRELAAS
BR7000491U (en)	1991-10-22	LOTERIA ZOONUMERICA FUTEBOLISTICA
BR7002566U (en)	1992-10-06	ALUVIONAR MINERATOR
BR7001392U (en)	1992-01-21	LIXA
BR7001143U (en)	1991-01-22	MINITECNIGRAFO
BR7000857U (en)	1991-11-19	ACUCAREIRO DOSADOR
BR7000792U (en)	1992-11-03	MICROBEED
BR7000675U (en)	1991-10-22	MINIBOIA
BR7000649U (en)	1990-11-06	AUTOAR
BR7001859U (en)	1992-04-28	PROTELETRON
BR7000375U (en)	1991-10-01	MOSQUITEIRO BABY-JU
BR7000286U (en)	1991-10-01	BAGAGER
BR7001930U (en)	1992-05-05	TERRARIO